메뉴 건너뛰기




Volumn 69, Issue 1, 2012, Pages 35-39

Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy

Author keywords

Amino acids; Anticonvulsants; Dosage; Encephalopathy; Hyperammonemia; L Carnitine; Metabolism; Toxicity; Valproic acid

Indexed keywords

2 PROPYL 2 PENTENOIC ACID; 2 PROPYL 4 PENTENOIC ACID; ACTIVATED CARBON; AMMONIA; CARBAMAZEPINE; CARNITINE; DRUG METABOLITE; ELECTROLYTE; GLUTAMIC ACID; LACTULOSE; NALOXONE; PHENOBARBITAL; PHENYTOIN; SHORT CHAIN FATTY ACID; VALPROATE SEMISODIUM; VALPROIC ACID;

EID: 84855267416     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110049     Document Type: Review
Times cited : (72)

References (25)
  • 1
    • 84855273419 scopus 로고    scopus 로고
    • accessed 2009 Sep 21
    • Lexi-Drugs Online. Valproic acid. www.crlonline.com/crlonline (accessed 2009 Sep 21).
    • Valproic Acid
  • 3
    • 84855273419 scopus 로고    scopus 로고
    • POISINDEX Management. accessed 2009 Sep 21
    • POISINDEX Management. Valproic acid. www.thomsonhc.com (accessed 2009 Sep 21).
    • Valproic Acid
  • 4
    • 70350463946 scopus 로고    scopus 로고
    • Carnitine in the treatment of valproic acid-induced toxicity
    • Lheureux P, Hantson P. Carnitine in the treatment of valproic acid-induced toxicity. Clin Toxicol. 2009; 47:101-11.
    • (2009) Clin Toxicol. , vol.47 , pp. 101-111
    • Lheureux, P.1    Hantson, P.2
  • 6
    • 27144539588 scopus 로고    scopus 로고
    • Science review: Carnitine in the treatment of valproic acid-induced toxicity - What is the evidence?
    • DOI 10.1186/cc3742
    • Lheureux P, Penaloza A, Zahir S et al. Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence? Crit Care. 2005; 9:431-40. (Pubitemid 41498538)
    • (2005) Critical Care , vol.9 , Issue.5 , pp. 431-440
    • Lheureux, P.E.R.1    Penaloza, A.2    Zahir, S.3    Gris, M.4
  • 8
    • 0019941501 scopus 로고
    • Carnitine deficiency and hyperammonemia associated with valproic acid therapy
    • DOI 10.1016/S0022-3476(82)80320-X
    • Ohtani Y, Endo F, Matsuda I. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr. 1982; 101:782-5. (Pubitemid 12006715)
    • (1982) Journal of Pediatrics , vol.101 , Issue.5 , pp. 782-785
    • Ohtani, Y.1    Endo, F.2    Matsuda, I.3
  • 10
    • 4644320399 scopus 로고    scopus 로고
    • Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman
    • DOI 10.1345/aph.1E063
    • Mallet L, Babin S, Morals JA. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman. Ann Pharmacother. 2004; 38:1643-7. (Pubitemid 39297762)
    • (2004) Annals of Pharmacotherapy , vol.38 , Issue.10 , pp. 1643-1647
    • Mallet, L.1    Babin, S.2    Morais, J.A.3
  • 11
    • 0023185385 scopus 로고
    • l-Carnitine: A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism
    • Goa KL, Brogden RN. L-carnitine: a preliminary review of its pharmacokinetics, and its therapeutic use in ischemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism. Drugs. 1987; 34:1-24. (Pubitemid 17092320)
    • (1987) Drugs , vol.34 , Issue.1 , pp. 1-24
    • Goa, K.L.1    Brogden, R.N.2
  • 12
    • 84855258187 scopus 로고    scopus 로고
    • Gaithersburg, MD: Sigma-Tau Pharmaceuticals, Inc.
    • Carnitor (levocarnitine) package insert. Gaithersburg, MD: Sigma-Tau Pharmaceuticals, Inc.; 2004.
    • (2004) Carnitor (Levocarnitine) Package Insert
  • 13
    • 0018645903 scopus 로고
    • Treatment of accidental sodium valproate overdose with an opiate antagonist
    • Steiman GS, Woerpel RW, Sherard ES Jr. Treatment of accidental sodium valproate overdose with an opiate antagonist. Ann Neurol. 1979; 6:274. (Pubitemid 9253603)
    • (1979) Annals of Neurology , vol.6 , Issue.3 , pp. 274
    • Steiman, G.S.1    Woerpel, R.W.2    Sherard Jr., E.S.3
  • 15
    • 0033057097 scopus 로고    scopus 로고
    • Naloxone in the reversal of coma induced by sodium valproate
    • Montero FJ. Naloxone in the reversal of coma induced by sodium valproate. Ann Emerg Med. 1999; 33:357-8.
    • (1999) Ann Emerg Med. , vol.33 , pp. 357-358
    • Montero, F.J.1
  • 17
    • 77954584445 scopus 로고    scopus 로고
    • L-carnitine for acute valproic acid overdose: A systematic review of published cases
    • Perrott J, Murphy NG, Zed PJ. L-carnitine for acute valproic acid overdose: a systematic review of published cases. Ann Pharmcother. 2010; 44:1287-93.
    • (2010) Ann Pharmcother. , vol.44 , pp. 1287-1293
    • Perrott, J.1    Murphy, N.G.2    Zed, P.J.3
  • 18
    • 0034018410 scopus 로고    scopus 로고
    • The role of carnitine supplementation during valproic acid therapy
    • Raskind JY, El-Chaar GM. The role of carnitine supplementation during valproic acid therapy. Ann Pharmacother. 2000; 34:630-8. (Pubitemid 30257492)
    • (2000) Annals of Pharmacotherapy , vol.34 , Issue.5 , pp. 630-638
    • Raskind, J.Y.1    El-Chaar, G.M.2
  • 19
    • 19544380424 scopus 로고    scopus 로고
    • L-carnitine was safely administered in the setting of valproate toxicity
    • DOI 10.1016/j.ajem.2005.02.015, PII S073567570500063X
    • LoVecchio F, Shriki J, Samaddar R. L-carnitine was safely administered in the setting of valproate toxicity. Am J Emerg Med. 2005; 23:321-2. (Pubitemid 40732266)
    • (2005) American Journal of Emergency Medicine , vol.23 , Issue.3 , pp. 321-322
    • LoVecchio, F.1    Shriki, J.2    Samaddar, R.3
  • 20
    • 0034787976 scopus 로고    scopus 로고
    • Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy
    • Barrueto F, Hack JB. Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy. Acad Emerg Med. 2001; 8:999-1001. (Pubitemid 32954755)
    • (2001) Academic Emergency Medicine , vol.8 , Issue.10 , pp. 999-1001
    • Barrueto Jr., F.1    Hack, J.B.2
  • 21
    • 85046172690 scopus 로고    scopus 로고
    • Carnitine for valproic acid-induced hyperammonemia
    • Raby WN. Carnitine for valproic acid-induced hyperammonemia. Am J Psychiatry. 1997; 154:8-9.
    • (1997) Am J Psychiatry. , vol.154 , pp. 8-9
    • Raby, W.N.1
  • 22
    • 27144445725 scopus 로고    scopus 로고
    • Severe hyperammonemic encephalopathy shortly after valproic acid prescription and rapid awakening following levocarnitine
    • Borbath I, de Barsy TH, Jeanjean A et al. Severe hyperammonemic encephalopathy shortly after valproic acid prescription and rapid awakening following levocarnitine. J Toxicol Clin Toxicol. 2000; 38:219-20.
    • (2000) J Toxicol Clin Toxicol. , vol.38 , pp. 219-220
    • Borbath, I.1    De Barsy, T.H.2    Jeanjean, A.3
  • 23
    • 37549011032 scopus 로고    scopus 로고
    • Severe acute hyperammonemia after brief exposure to valproate
    • Eubanks AL, Aquirre B, Bourgeois JA. Severe acute hyperammonemia after brief exposure to valproate. Psychosomatics. 2008; 49:82-3.
    • (2008) Psychosomatics. , vol.49 , pp. 82-83
    • Eubanks, A.L.1    Aquirre, B.2    Bourgeois, J.A.3
  • 24
    • 12144265811 scopus 로고    scopus 로고
    • Comparison of clinical, magnetic resonance and evoked potentials data in a case of valproic-acid-related hyperammonemic coma
    • DOI 10.1007/s00330-004-2338-9
    • Hantson P, Grandin C, Duprez T et al. Comparison of clinical, magnetic resonance and evoked potentials data in a case of valproic-acid-related hyperammonemic coma. Eur Radiol. 2005; 15:59-64. (Pubitemid 40109771)
    • (2005) European Radiology , vol.15 , Issue.1 , pp. 59-64
    • Hantson, P.1    Grandin, C.2    Duprez, T.3    Nassogne, M.-C.4    Guerit, J.-M.5
  • 25
    • 34247622195 scopus 로고    scopus 로고
    • Carnitine as an antidote for acute valproate toxicity in children
    • DOI 10.1097/MOP.0b013e32805e879a, PII 0000848020070400000016
    • Russell S. Carnitine as an antidote for acute valproate toxicity in children. Curr Opin Pediatr. 2007; 19:206-10. (Pubitemid 46668075)
    • (2007) Current Opinion in Pediatrics , vol.19 , Issue.2 , pp. 206-210
    • Russell, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.